EuReCa ONE—27 Nations, ONE Europe, ONE Registry A prospective one month analysis of out-of-hospital cardiac arrest outcomes in 27 countries in Europe

AbstractIntroductionThe aim of the EuReCa ONE study was to determine the incidence, process, and outcome for out of hospital cardiac arrest (OHCA) throughout Europe.MethodsThis was an international, prospective, multi-centre one-month study. Patients who suffered an OHCA during October 2014 who were attended and/or treated by an Emergency Medical Service (EMS) were eligible for inclusion in the study. Data were extracted from national, regional or local registries.ResultsData on 10,682 confirmed OHCAs from 248 regions in 27 countries, covering an estimated population of 174 million. In 7146 (66%) cases, CPR was started by a bystander or by the EMS. The incidence of CPR attempts ranged from 19.0 to 104.0 per 100,000 population per year. 1735 had ROSC on arrival at hospital (25.2%), Overall, 662/6414 (10.3%) in all cases with CPR attempted survived for at least 30 days or to hospital discharge.ConclusionThe results of EuReCa ONE highlight that OHCA is still a major public health problem accounting for a substantial number of deaths in Europe.EuReCa ONE very clearly demonstrates marked differences in the processes for data collection and reported outcomes following OHCA all over Europe. Using these data and analyses, different countries, regions, systems, and concepts can benchmark themselves and may learn from each other to further improve survival following one of our major health care events

Etat des lieux de la grippe en pédiatrie

LIMOGES-BU Médecine pharmacie (870852108) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF

Etude de la diversification alimentaire chez 109 nourrissons âgés de 3 mois à 1 an, résident en Haute-Vienne en 2009 (pratiques parentales, pratiques médicales)

Objectif : Définir les modalités de la diversification alimentaire chez les nourrissons âgés de 3 mois à un an résidents en Haute-Vienne, gardés en crèche ou bien consultant en PMI. Méthode : Enquête à travers un questionnaire anonyme auprès de parents de 109 nourrissons gardés en crèche ou consultant en PMI. Enquête auprès des professionnels de santé susceptibles de s occuper de ces mêmes nourrissons (médecins généralistes, médecins pédiatres et médecins de PMI). Résultats : L allaitement maternel exclusif reste en deçà des recommandations de l OMS notamment pour les bébés à risque d atopie. La diversification alimentaire des nourrissons étudiés est en conformité avec les recommandations du PNNS et l AFSSA. Nous n avons pas retrouvé de facteur influençant l âge de début de la diversification alimentaire si ce n est peut être un jeune âge de la mère (20 à 25 ans). Les parents de notre enquête semblent avoir obtenu les informations nécessaires quant à la diététique infantile auprès des différents professionnels de santé et de la petite enfance. Les informations reçues semblent être en conformité avec les différentes recommandations. Conclusion : Malgré ces résultats encourageants, nous avons identifié quelques pistes d amélioration concernant les conseils prodigués par les professionnels de santé et de la petite enfance : Promouvoir et informer sur l allaitement maternel lors du suivi de la grossesse. Différer le début de la diversification alimentaire chez les nourrissons à risque d atopie. Préciser les aspects qualitatifs et quantitatifs du bol alimentaire : intérêts et places des graisses alimentaires, des boissons sucrées et des protéines. Encourager les professionnels de santé à consulter davantage encore les annexes nutritionnelles du carnet de santé de l enfant.LIMOGES-BU Médecine pharmacie (870852108) / SudocSudocFranceF

Paludisme d'importation chez l'enfant en France (à propos de trente enfants de moins de 15 ans hospitalisés dans le service de pédiatrie du CHU de Limoges de 1993 à 2002)

LIMOGES-BU Médecine pharmacie (870852108) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF

Childhood cancer survival in France, 1990-1999.

ERMAInternational audienceThe aim of this study was to describe the overall survival after childhood cancer in France using follow-up data from regional population-based registries. The survival of children (aged under 15 years) diagnosed with a cancer during 1990-1999 was analysed. For all cancers, the survivals were, respectively, 90.3% [89.4-91.3] at 1-year, 75.2% [73.8-76.6] at 5 years and 72.2% [70.7-73.7] at 10 years. During the 1990s, the average improvement in the 5-year survival was +1.2% per year. Adjusted for gender, age, area of residence and stage, children with cancer diagnosed between 1995 and 1999 had a 0.80 reduced risk of dying compared with those whose cancer had been diagnosed between 1990 and 1994. The increase of survival at the population level reflects a global improvement in childhood cancer care. The Paediatric Registries, in association with the French Society of Childhood Cancer, are now collecting data to quantify on a national basis the other events, at least relapse and second cancers

Cancer incidence among children in France, 1990-1999.

International audienceBACKGROUND: Cancer is the second most important cause of death for children aged less than 15 years in France, unintentional injuries being the leading cause. The aim of the present study was to estimate the incidence of childhood cancer from six Childhood Cancer Registries covering 32% of France. PROCEDURE: Incident cancer cases diagnosed between 1990 and 1999 in children (0-14 years) resident in the administrative areas covered by each Registry were included. Annual age-standardized rates (ASRs) were adjusted by the world population. The estimated annual percent change (EAPC) was used to measure trend towards changes in the annual age-standardized incidence rate. RESULTS: With 4234 registered cases, the ASRs per million children were 137.5 for all cancers combined, 42.3 for leukemia, 29.1 for central-nervous-system tumors, 15.6 for lymphomas, 14.1 for sympathetic-nervous-system tumors, and 9.1 for renal tumors. The ASR of all cancers combined was slightly higher in males (145.8 per million children) than in females (128.7 per million children) with an M/F ratio of 1.2. No significant incidence trend was observed, with an EAPC of +0.2% [IC 95% (-2.5; +3.0); P = 0.89]. CONCLUSIONS: The estimated incidence rates are similar to those reported in previous studies in European and North American countries. These results will contribute to the development of National Registration of Childhood Cancer in France and support the national research program on childhood cancer

Familial history of cancer and childhood acute leukemia: a French population-based case-control study.

International audienceA case-control study was conducted to investigate the role of a familial history of cancer in the etiology of childhood acute leukemia. The history of cancer in the relatives of 472 cases was compared with that of 567 population-based controls. Recruitment was frequency matched on age, sex and region. The familial history of cancer in each child's relatives was reported by the mother in response to a standardized self-administered questionnaire. A familial history of solid tumor in first or second-degree relatives was associated with an increased risk of acute lymphoblastic leukemia (odds ratio (OR)=1.6 [95% confidence interval, 1.2-2.1]), while a familial history of hematopoietic malignancies in first or second-degree relatives was associated with an increased risk of acute myeloid leukemia (OR=4.3 [1.4-13]). The ORs for the histories of cancer increased with the number of relatives with cancer (OR=1.5 [1.1-2.0] for one relative and OR=2.3 [1.3-3.8] for two relatives or more; Ptrend<0.0001). Significant associations between childhood acute leukemia and familial history of genital cancers and brain tumor were also observed (OR=2.7 [1.2-5.8] and OR=10.7 [1.3-86], respectively). This study supports the hypothesis that a familial history of cancer may play a role in the etiology of childhood acute leukemia. It also evidences some specific associations that require further investigation